232 Th-Spallation-Produced 225 Ac with Reduced 227 Ac Content

Inorganic Chemistry
Andrew Kyle Henderson RobertsonPaul Schaffer

Abstract

Recent clinical results have demonstrated remarkable treatment responses of late-stage cancer patients when treated with alpha-emitting radionuclides such as actinium-225 (225Ac). The resulting intense global effort to produce greater quantities of 225Ac has triggered a number of emerging technologies to produce this rare, yet important, radionuclide. Accelerator-based methods for increasing global 225Ac production capacity have focused on the high energy (>100 MeV) proton irradiation of thorium, despite the coproduction of the undesirable 227Ac byproduct at 0.1-0.3% of the 225Ac activity. We at TRIUMF have developed a process for the production of a 225Ra/225Ac generator from irradiated thorium that results in an 225Ac product with reduced 227Ac content. 225Ac was separated from irradiated thorium and coproduced radioactive spallation and fission products using a thorium peroxide precipitation method followed by cation exchange and extraction chromatography. Stable and radioactive tracer studies demonstrated the ability of this method to separate Ac from most other elements, providing a directly produced Ac product with measured 227Ac content of (0.15 ± 0.04)%. A second, indirectly produced Ac product with 227Ac content of <7....Continue Reading

References

Nov 1, 1988·International Journal of Radiation Biology·D Blöcher
Feb 1, 1993·Nuclear Medicine Communications·M W GeerlingsR van der Hout
Sep 2, 1998·European Journal of Nuclear Medicine·M R McDevittD A Scheinberg
Oct 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M S KaminskiJ M Vose
Nov 17, 2001·Science·M R McDevittD A Scheinberg
Mar 15, 2005·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·Rose A BollSaed Mirzadeh
Apr 21, 2005·European Journal of Nuclear Medicine and Molecular Imaging·Olivier CouturierMichel Cherel
Oct 1, 2005·Analytical Chemistry·C ApostolidisA Morgenstern
Nov 10, 2007·Dalton Transactions : an International Journal of Inorganic Chemistry·Martin W Brechbiel
Nov 9, 2011·Nature Reviews. Clinical Oncology·Jean-Pierre PougetDavid Azria
Dec 7, 2011·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Young-Seung Kim, Martin W Brechbiel
Sep 4, 2012·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·J W WeidnerF M Nortier
Sep 5, 2012·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·J W WeidnerF M Nortier
Dec 12, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kwamena E BaidooMartin W Brechbiel
Jul 19, 2013·The New England Journal of Medicine·C ParkerUNKNOWN ALSYMPCA Investigators
Jan 25, 2014·Frontiers in Oncology·Jörgen ElgqvistPer Albertsson
May 27, 2014·American Society of Clinical Oncology Educational Book·Joseph G Jurcic, Todd L Rosenblat
Jul 9, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Clemens KratochwilAlfred Morgenstern
Oct 25, 2016·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·J R GriswoldS Mirzadeh
Jan 12, 2017·The New England Journal of Medicine·Jonathan StrosbergUNKNOWN NETTER-1 Trial Investigators
Apr 15, 2017·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Uwe HaberkornClemens Kratochwil
Aug 16, 2017·Scientific Reports·Tara MastrenMichael E Fassbender
Jan 13, 2018·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Clemens KratochwilAlfred Morgenstern
Mar 3, 2018·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Sophie PotyJason S Lewis
Apr 17, 2018·Current Radiopharmaceuticals·Andrew Kyle Henderson RobertsonValery Radchenko
Apr 20, 2018·Current Radiopharmaceuticals·Jonathan W Engle
Sep 21, 2018·European Journal of Nuclear Medicine and Molecular Imaging·Mike SathekgeAlfred Morgenstern

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Nuclear Medicine and Molecular Imaging
Kotaro NagatsuMing-Rong Zhang
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
Rose A BollSaed Mirzadeh
Cancer Biotherapy & Radiopharmaceuticals
Stephen J KennelSaed Mirzadeh
© 2021 Meta ULC. All rights reserved